The National Institute for Health and Clinical
Excellence (NICE)
NICE’s current guidance on the prevention,
identification, assessment and management of overweight and obesity
is based on the best currently available evidence of
effectiveness.
Current treatment options recommended by NICE
in clinical guideline 43 include low-calorie diets (LCDs) and
very-low-calorie diets (VLCDs).
Low-calorie diets may also be considered,
but are less likely to be nutritionally complete.
The LighterLife Lite
low-calorie diet
is nutritionally balanced, combining conventional food with
nutritionally balanced formula foods to provide key nutrients.
Very-low-calorie diets may be used for a
maximum of 12 weeks continuously, or intermittently with a
low-calorie diet (for example for two to four days a week), by
people who are obese and have reached a plateau in weight loss. Any
diet of less than 600 kcal/day should be used only under clinical
supervision.
The LighterLife Total
very-low-calorie diet is available for suitably obese
patients following GP assessment, is clinically supervised and is
followed for no more than 12 weeks continuously.
In the longer term, people should move
towards eating a balanced diet, consistent with other
healthy eating advice.
LighterLife’s weight-management stage is based around healthy eating
principles, according to national guidelines.
LighterLife’s weight-loss programmes offer
patients the opportunity to use and develop behavioural-change
techniques recommended by NICE, including:
- Cognitive behavioural
therapy (CBT)
techniques.
- Self-monitoring of behaviour and progress, including goal
setting and keeping a food and mood diary.
- Strategies for preventing and coping with lapses and
‘high-risk’ situations.
Read more information on NICE guidelinesregarding the treatment of
obesity and their recommendation that the NHS should consider
working with commercial weight-management programmes.
NICE, Obesity: guidance on the prevention,
identification, assessment and management of overweight and obesity
in adults and children, clinical guideline 43, London Dec
2006.